Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 30 Records) |
Query Trace: Arthritis and ABCB1[original query] |
---|
ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. Clinical and experimental rheumatology 0 24 (5): 546-54. Takatori R, Takahashi K A, Tokunaga D, Hojo T, Fujioka M, Asano T, Hirata T, Kawahito Y, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo |
ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Scandinavian journal of gastroenterology 2007 Jun 42 (6): 726-33. Fischer Simon, Lakatos Peter Laszlo, , Lakatos Laszlo, Kovacs Agota, Molnar Tamas, Altorjay Istvan, Papp Maria, Szilvasi Aniko, Tulassay Zsolt, Osztovits Janos, Papp Janos, Demeter Pal, Schwab Richard, Tordai Attila, Andrikovics Hajnal |
Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. The Journal of rheumatology 2008 Apr 35 (4): 572-9. Ranganathan Prabha, Culverhouse Robert, Marsh Sharon, Mody Ami, Scott-Horton Tiffany J, Brasington Richard, Joseph Amy, Reddy Virginia, Eisen Seth, McLeod Howard |
Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis. Pharmacogenomics 2010 Feb 11 (2): 163-75. Kooloos Wouter M, Wessels Judith Am, van der Straaten Tahar, Allaart Cornelia F, Huizinga Tom Wj, Guchelaar Henk-J |
Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis. Drug metabolism and pharmacokinetics 2012 27 (2): 192-9. Kato Tomomi, Hamada Akinobu, Mori Shunsuke, Saito Hideyu |
ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis. The Journal of rheumatology 2012 Oct 39 (10): 2032-40. de Rotte Maurits C F J, Bulatovic Maja, Heijstek Marloes W, Jansen Gerrit, Heil Sandra G, van Schaik Ron H N, Wulffraat Nico M, de Jonge Robe |
Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis. Annals of the rheumatic diseases 2012 Sep 71 (9): 1484-9. Bulatovic Maja, Heijstek Marloes W, Van Dijkhuizen E H Pieter, Wulffraat Nico M, Pluijm Saskia M F, de Jonge Robe |
Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. Omics : a journal of integrative biology 2012 Nov 16 (11): 589-95. Plaza-Plaza José Cristian, Aguilera Margarita, Cañadas-Garre Marisa, Chemello Clarice, González-Utrilla Alfonso, Faus Dader María José, Calleja Miguel Ang |
Association of the ABCB1 C3435T polymorphism with responsiveness to and toxicity of DMARDs in rheumatoid arthritis : A meta-analysis. Zeitschrift fur Rheumatologie 2015 Jul . Lee Y H, Bae S-C, Song G |
ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis. Clinica chimica acta; international journal of clinical chemistry 2015 May 445 79-84. Naito Takafumi, Mino Yasuaki, Aoki Yuki, Hirano Kumi, Shimoyama Kumiko, Ogawa Noriyoshi, Kagawa Yoshiyuki, Kawakami Junic |
Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients. Pharmacogenomics 2015 Dec . Moya Patricia, Salazar Juliana, Arranz María Jesús, Díaz-Torné César, Del Río Elisabeth, Casademont Jordi, Corominas Hèctor, Baiget Montserr |
Impact of MTHFR rs1801133, MTHFR rs1801131 and ABCB1 rs1045642 polymorphisms with increased susceptibility of rheumatoid arthritis in the West Algerian population: A case-control study. Acta reumatologica portuguesa 0 40 (4): 363-371. Boughrara W, Aberkane M, Fodil M, Benzaoui A, Dorgham S, Zemani F, Dahmani C, Petit-Teixeira E, Boudjema |
Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population. Journal of pharmaceutical health care and sciences 2016 2 35. Hashiguchi Masayuki, Shimizu Mikiko, Hakamata Jun, Tsuru Tomomi, Tanaka Takanori, Suzaki Midori, Miyawaki Kumika, Chiyoda Takeshi, Takeuchi Osamu, Hiratsuka Jiro, Irie Shin, Maruyama Junya, Mochizuki Mayu |
Impact of genetic variants of ATP binding cassette B1, AICAR transformylase/IMP cyclohydrolase, folyl-polyglutamatesynthetase, and methylenetetrahydrofolatereductase on methotrexate toxicity. Reumatologia clinica 2016 Oct . Sala-Icardo Luis, Lamana Amalia, Ortiz Ana María, García Lorenzo Elena, Moreno Fresneda Pablo, García-Vicuña Rosario, González-Álvaro Isido |
Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis. Scientific reports 2017 Mar 7 44015. Qiu Qi, Huang Jing, Shu Xiaoming, Fan Huizheng, Zhou Youwen, Xiao Che |
No correlation between MTHFR c.677 C?>?T, MTHFR c.1298 A?>?C, and ABCB1 c.3435 C?>?T polymorphisms and methotrexate therapeutic outcome of rheumatoid arthritis in West Algerian population. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2017 Mar . Boughrara Wefa, Benzaoui Ahmed, Aberkane Meriem, Moghtit Fatima Zohra, Dorgham Samia, Lardjam-Hetraf Aicha Sarah, Ouhaibi-Djellouli Hadjer, Teixeira Elisabeth Petit, Boudjema Abdall |
Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study. Modern rheumatology 2017 Dec 1-27. Hakamata Jun, Hashiguchi Masayuki, Kaneko Yuko, Yamaoka Kunihiro, Shimizu Mikiko, Maruyama Junya, Takeuchi Tsutomu, Mochizuki Mayu |
Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients. Clinical rheumatology 2018 Jul . Sandhu Amit, Ahmad Shabeer, Kaur Jasbinder, Bhatnagar Archana, Dhawan Veena, Dhir Var |
Development and validation of a prognostic multivariable model to predict insufficient clinical response to methotrexate in rheumatoid arthritis. PloS one 2018 12 13 (12): e0208534. de Rotte Maurits C F J, Pluijm Saskia M F, de Jong Pascal H P, Bulatovi? ?alasan Maja, Wulffraat Nico M, Weel Angelique E A M, Lindemans Jan, Hazes J M W, de Jonge Robe |
Association between ABCB1 C3435T polymorphism and methotrexate treatment outcomes in rheumatoid arthritis patients: a meta-analysis. Pharmacogenomics 2019 Apr . He Xiao, Sun Mingfang, Liang Shenju, Li Mengshan, Li Liangliang, Yang |
Optimization of Individual Pharmacotherapy Based on Multiple Evaluations of Patient Data. Biological & pharmaceutical bulletin 2019 2 42 (2): 149-157. Naito Takafu |
Clinical and Laboratory Associations with Methotrexate Metabolism Gene Polymorphisms in Rheumatoid Arthritis. Journal of personalized medicine 2020 9 10 (4): . D'Cruz Leon G, McEleney Kevin G, Tan Kyle B C, Shukla Priyank, Gardiner Philip V, Connolly Patricia, Conway Caroline, Cobice Diego, Gibson David |
Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis. Therapeutic advances in chronic disease 2020 11 2040622320916026. Huang Jing, Fan Huizhen, Qiu Qi, Liu Kunpeng, Lv Shuang, Li Jiang, Yang Hui, Shu Xiaoming, Xu Yuan, Lu Xiangchen, Lu Cheng, Zhang Yunnan, Xiao Che |
The impacts of gene polymorphisms on methotrexate in Chinese psoriatic patients. Journal of the European Academy of Dermatology and Venereology : JEADV 2020 4 34 (9): 2059-2065. Chen M, Chen W, Liu P, Yan K, Lv C, Zhang M, Lu Y, Qin Q, Kuang Y, Zhu W, Chen |
Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis. Pediatric rheumatology online journal 2021 Apr 19 (1): 51. Kyvsgaard Nini, Mikkelsen Torben Stamm, Als Thomas D, Christensen Anne Estmann, Corydon Thomas J, Herlin Troe |
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report. Pharmacogenomics and personalized medicine 2022 5 15 465-475. Jeiziner Chiara, Allemann Samuel S, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study. Pharmacogenomics and personalized medicine 2022 4 15 327-339. Cen Han, Wen Qin-Wen, Zhang Han-Qing, Yu Hang, Zeng Zhen, Jin Ting, Wang Ting-Hui, Qin Wen, Huang Hua, Wu Xiu- |
The HLA-Cw*06 allele may predict the response to methotrexate (MTX) treatment in Chinese arthritis-free psoriasis patients. Archives of dermatological research 2022 12 . Mao Manyun, Kuang Yehong, Chen Menglin, Yan Kexiang, Lv Chenzhi, Liu Panpan, Lu Yan, Chen Xiang, Zhu Wu, Chen Wangqi |
Can we predict unresponsiveness to methotrexate in rheumatoid arthritis? A pharmacogenetic study. Inflammopharmacology 2022 Jan . Melikoglu Meltem Alkan, Balkan E |
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 2023 6 15 (6): . Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLere |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: